Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$40,040,787
New position
Shares Held
203,026
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in AZN
reported options exposure · as of Mar 31, 2026CallValue
$788,880
CallShares
4,000
PutValue
$1,183,320
PutShares
6,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $1,148,943,923 across 14 Drug Manufacturers - General names. AZN ranks #4 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,535,106 | $699,604,178 | |
| 2 | NVO |
Novo Nordisk A S
|
6,286,501 | $231,028,911 | |
| 3 | LLY |
ELI LILLY & Co
|
64,550 | $59,371,153 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
203,026 | $40,040,787 | |
| 5 | ABBV |
AbbVie Inc.
|
178,418 | $38,804,130 | |
| 6 | AMGN |
Amgen Inc
|
71,680 | $25,220,608 | |
| 7 | OGN |
Organon & Co.
|
3,137,020 | $18,790,749 | |
| 8 | JNJ |
Johnson & Johnson
|
53,253 | $13,017,163 |
All Filings in AZN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,040,787 | 203,026 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,183,320 | 6,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $788,880 | 4,000 | Call | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||